Drug Discovery and Development: New Options for Old Diseases II

Dear Colleagues,

Inflammatory or tumoral diseases have caused a significant increase in the number of cases each year. Chronic diseases, such as endometriosis, Crohn's syndrome, diabetic neuropathy, neuropathic pain, are some examples of conditions without specific treatment that are responsible for a large number of patients. In addition, they are also responsible for increasing leave from work. This causes damage to both companies and workers. Thus, the search for new molecules, both synthetic and of natural origin, that can be studied as potential treatments for the most diverse pathologies is urgent. In addition, drug repositioning is an interesting strategy that can lead to less costs in the process of discovering a new drug. Potential topics include, but are not limited to: New molecules for treating inflammatory diseases (i.e., endometriosis, inflammatory bowel disease); Search of new molecules for treating pain diseases (i.e., neurophatic pain); New molecules with antitumoral effects describing the possible mechanism of action; New molecules or isolated substances from natural origin in treating chronic diseases; Mechanisms of action describing the new molecules in vitro and/or in vivo disease models; Reporsitioning of old drugs in new possible treatments.

Dr. Patricia Dias Fernandes
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer
• endometriosis
• crohn disease
• inflammatory bowel disease
• neurophatic pain
• inflammation

• Drug Discovery and Development: New Options for Old Diseases in Molecules (12 articles)